Jump to navigation
The latest clinical and political news for Australian Rheumatologists
GPs are more likely to offer medication than to refer, BEACH data shows.
It is the disease's 'most devasting' extra-articular manifestation
This goal is achievable in most children thanks to therapeutic advances, the experts say.
It's important to encourage these patients to quit smoking, researchers say.
Results from a large UK study.
But some say the data is insufficient to rule out a benefit in acute cases.
A trial shows patients had improved symptoms and reduced analgesia.
The development of highly specific antibodies known as biologics requires a mix of inspiration and good fortune
Differences in the oral microbiome in Sjögren’s may be due to lack of saliva.
It is inefficacious for a third of patients: study
But there's five pathological causes to watch for, experts say.
The interleukin-17A inhibitor also benefited the joints.
In the first year the effects differ depending on the agent.
Study shows women on TNF alpha inhibitors are at no increased risk.
You might be surprised.
Large study compares the effect with patients on allopurinol.
Some proceduralists' risks rival that of labourers, a meta-analysis shows.
The country is out on a limb.
It's a more common comorbidity than you think.
Study fails to back off-label use.
Australian Doctor Group (ADG) is Australia’s premier business to business publisher, delivering the country’s most recognised industry magazines and websites.
Ensure you never miss a big story by signing up for our daily e-newsletter.